Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411

Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging

(2016) Nithya Subramanian et al.   Molecular Therapy-Nucleic Acids

Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination

(2015) Nuno A. Fonseca et al.   BIOMATERIALS

Study of the Function of G-Rich Aptamers Selected for Lung Adenocarcinoma

(2015) Jun Hu et al.   Chemistry-An Asian Journal

Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach

(2015) Sarandeep Malhi et al.   Expert Opinion on Drug Delivery

Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation

(2015) E. Merit Reyes-Reyes et al.   Molecular Oncology

Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin

(2015) Ling-Yen Chung et al.   Oncotarget

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014) M. Reck et al.   ANNALS OF ONCOLOGY

Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy

(2014) Yinan Zhong et al.   BIOMACROMOLECULES

Peptide receptor therapies in neuroendocrine tumors

(2014) L. Bodei et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Evaluation of Cobalt-Labeled Octreotide Analogs for Molecular Imaging and Auger Electron-Based Radionuclide Therapy

(2014) H. Thisgaard et al.   JOURNAL OF NUCLEAR MEDICINE

Cancer stem cell detection and isolation

(2014) Meysam Moghbeli et al.   MEDICAL ONCOLOGY

Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Patients With Somatostatin Receptor–Expressing Neuroendocrine Tumors

(2014) Ebrahim S. Delpassand et al.   PANCREAS

Cell Surface Nucleolin as a Target for Anti-Cancer Therapies

(2014) Marina Koutsioumpa et al.   Recent Patents on Anti-Cancer Drug Discovery

Multifunctional Nucleic Acids for Tumor Cell Treatment

(2014) Monika Pofahl et al.   Nucleic Acid Therapeutics

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

(2013) Jonathan E. Rosenberg et al.   INVESTIGATIONAL NEW DRUGS

Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells

(2013) Monica Charpentier et al.   Cancers

Heat Shock Cognate 70 Regulates the Translocation and Angiogenic Function of Nucleolin

(2012) Yanping Ding et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The Future of Peptide-based Drugs

(2012) David J. Craik et al.   Chemical Biology & Drug Design

MicroRNA Delivery by Cationic Lipoplexes for Lung Cancer Therapy

(2011) Yun Wu et al.   MOLECULAR PHARMACEUTICS

Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice

(2010) Diala El Khoury et al.   BMC CANCER

A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism

(2010) E. M. Reyes-Reyes et al.   CANCER RESEARCH

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

(2009) G. Bertolini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA